{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:55:23Z","timestamp":1771631723268,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,21]]},"DOI":"10.7759\/cureus.72063","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:07:36Z","timestamp":1729555656000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Myeloperoxidase Antineutrophil Cytoplasmic Antibody (MPO-ANCA)-Positive Membranoproliferative Glomerulonephritis With Latent Tuberculosis Infection"],"prefix":"10.7759","author":[{"given":"Ami","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemasa","family":"Gotoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsumasa","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Mima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1322-7","article-title":"Membranoproliferative glomerulonephritis","volume":"25","author":"Alchi B","year":"2010","unstructured":"Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol. 2010, 25:1409-18. 10.1007\/s00467-009-1322-7","journal-title":"Pediatr Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000084","article-title":"Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk","volume":"69","author":"Little MA","year":"2006","unstructured":"Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int. 2006, 69:504-11. 10.1038\/sj.ki.5000084","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative glomerulonephritis--a new look at an old entity","volume":"366","author":"Sethi S","year":"2012","unstructured":"Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis--a new look at an old entity. N Engl J Med. 2012, 366:1119-31. 10.1056\/NEJMra1108178","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.1.25","article-title":"The diagnosis of glomerular diseases: acute glomerulonephritis and the nephrotic syndrome","volume":"161","author":"Madaio MP","year":"2001","unstructured":"Madaio MP, Harrington JT. The diagnosis of glomerular diseases: acute glomerulonephritis and the nephrotic syndrome. Arch Intern Med. 2001, 161:25-34. 10.1001\/archinte.161.1.25","journal-title":"Arch Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000180226","article-title":"Membranoproliferative hypocomplementemic glomerulonephritis","volume":"11","author":"West CD","year":"1973","unstructured":"West CD. Membranoproliferative hypocomplementemic glomerulonephritis. Nephron. 1973, 11:134-46. 10.1159\/000180226","journal-title":"Nephron"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.82","article-title":"Secondary membranoproliferative glomerulonephritis","volume":"47","author":"Rennke HG","year":"1995","unstructured":"Rennke HG. Secondary membranoproliferative glomerulonephritis. Kidney Int. 1995, 47:643-56. 10.1038\/ki.1995.82","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.5414\/CNP73167","article-title":"Successful treatment of membranoproliferative glomerulonephritis associated with hepatitis B and C virus simultaneous infection patient","volume":"73","author":"Mima A","year":"2010","unstructured":"Mima A, Iehara N, Matsubara T, et al.. Successful treatment of membranoproliferative glomerulonephritis associated with hepatitis B and C virus simultaneous infection patient. Clin Nephrol. 2010, 73:167-9.","journal-title":"Clin Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-32","article-title":"MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report","volume":"13","author":"Morizane R","year":"2012","unstructured":"Morizane R, Konishi K, Hashiguchi A, et al.. MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report. BMC Nephrol. 2012, 13:32. 10.1186\/1471-2369-13-32","journal-title":"BMC Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2017-0346","article-title":"PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis","volume":"56","author":"Mahler M","year":"2017","unstructured":"Mahler M, Damoiseaux J, Ballet V, et al.. PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis. Clin Chem Lab Med. 2017, 56:e27-30. 10.1515\/cclm-2017-0346","journal-title":"Clin Chem Lab Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg066","article-title":"Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis","volume":"42","author":"Flores-Su\u00e1rez LF","year":"2003","unstructured":"Flores-Su\u00e1rez LF, Cabiedes J, Villa AR, van der Woude FJ, Alcocer-Varela J. Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis. Rheumatology (Oxford). 2003, 42:223-9. 10.1093\/rheumatology\/keg066","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","article-title":"Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal\/permeability increasing protein and are detected after treatment initiation","volume":"28","author":"Esquivel-Valerio JA","year":"2010","unstructured":"Esquivel-Valerio JA, Flores-Su\u00e1rez LF, Rodr\u00edguez-Amado J, Garza-Elizondo MA, Rend\u00f3n A, Salinas-Carmona MC. Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal\/permeability increasing protein and are detected after treatment initiation. Clin Exp Rheumatol. 2010, 28:35-9.","journal-title":"Clin Exp Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-021-00626-6","article-title":"Mesangiocapillary glomerulonephritis complicating pulmonary tuberculosis","volume":"11","author":"Torpiano P","year":"2022","unstructured":"Torpiano P, Holwill S, Pace D. Mesangiocapillary glomerulonephritis complicating pulmonary tuberculosis. CEN Case Rep. 2022, 11:17-21. 10.1007\/s13730-021-00626-6","journal-title":"CEN Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118195","article-title":"Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation","volume":"96","author":"Rinder CS","year":"1995","unstructured":"Rinder CS, Rinder HM, Smith BR, et al.. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest. 1995, 96:1564-72. 10.1172\/JCI118195","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.09108.x","article-title":"Oxidants and iron in chronic kidney disease","author":"Shah SV","year":"2004","unstructured":"Shah SV. Oxidants and iron in chronic kidney disease. Kidney Int Suppl. 2004, S50-5. 10.1111\/j.1523-1755.2004.09108.x","journal-title":"Kidney Int Suppl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700445","article-title":"Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy","volume":"86","author":"Mima A","year":"2006","unstructured":"Mima A, Matsubara T, Arai H, et al.. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy. Lab Invest. 2006, 86:927-39. 10.1038\/labinvest.3700445","journal-title":"Lab Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-202994","article-title":"Glomerular VEGF resistance induced by PKC\u03b4\/SHP-1 activation and contribution to diabetic nephropathy","volume":"26","author":"Mima A","year":"2012","unstructured":"Mima A, Kitada M, Geraldes P, et al.. Glomerular VEGF resistance induced by PKC\u03b4\/SHP-1 activation and contribution to diabetic nephropathy. FASEB J. 2012, 26:2963-74. 10.1096\/fj.11-202994","journal-title":"FASEB J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.12400","article-title":"Obesity-associated glomerular inflammation increases albuminuria without renal histological changes","volume":"8","author":"Mima A","year":"2018","unstructured":"Mima A, Yasuzawa T, King GL, Ueshima S. Obesity-associated glomerular inflammation increases albuminuria without renal histological changes. FEBS Open Bio. 2018, 8:664-70. 10.1002\/2211-5463.12400","journal-title":"FEBS Open Bio"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62579-7","article-title":"Linagliptin affects IRS1\/Akt signaling and prevents high glucose-induced apoptosis in podocytes","volume":"10","author":"Mima A","year":"2020","unstructured":"Mima A, Yasuzawa T, Nakamura T, Ueshima S. Linagliptin affects IRS1\/Akt signaling and prevents high glucose-induced apoptosis in podocytes. Sci Rep. 2020, 10:5775. 10.1038\/s41598-020-62579-7","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2182225","article-title":"Protective effects of eicosapentaenoic acid on the glomerular endothelium via inhibition of EndMT in diabetes","volume":"2021","author":"Yasuzawa T","year":"2021","unstructured":"Yasuzawa T, Nakamura T, Ueshima S, Mima A. Protective effects of eicosapentaenoic acid on the glomerular endothelium via inhibition of EndMT in diabetes. J Diabetes Res. 2021, 2021:2182225. 10.1155\/2021\/2182225","journal-title":"J Diabetes Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/302691-a-case-of-myeloperoxidase-antineutrophil-cytoplasmic-antibody-mpo-anca-positive-membranoproliferative-glomerulonephritis-with-latent-tuberculosis-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:07:38Z","timestamp":1729555658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/302691-a-case-of-myeloperoxidase-antineutrophil-cytoplasmic-antibody-mpo-anca-positive-membranoproliferative-glomerulonephritis-with-latent-tuberculosis-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.72063","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,21]]}}}